163 related articles for article (PubMed ID: 8980371)
1. Recurrent Hodgkin's disease after bone marrow transplantation.
Shahab I; Greer JP; Beeker TA; Wolff SN; Collins RD; Cousar JB
Am J Clin Pathol; 1997 Jan; 107(1):74-80. PubMed ID: 8980371
[TBL] [Abstract][Full Text] [Related]
2. Composite lymphoma. A clinicopathologic analysis of nine patients with Hodgkin's disease and B-cell non-Hodgkin's lymphoma.
Gonzalez CL; Medeiros LJ; Jaffe ES
Am J Clin Pathol; 1991 Jul; 96(1):81-9. PubMed ID: 2069139
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous Hodgkin's disease: an immunohistochemical analysis.
Cerroni L; Beham-Schmid C; Kerl H
J Cutan Pathol; 1995 Jun; 22(3):229-35. PubMed ID: 7593816
[TBL] [Abstract][Full Text] [Related]
4. Primary mediastinal large B-cell lymphoma: a comparative study with nodular sclerosis-type Hodgkin's disease.
Yonetani N; Kurata M; Nishikori M; Haga H; Ohmori K; Yamabe H; Uchiyama T; Ohno H
Int J Hematol; 2001 Aug; 74(2):178-85. PubMed ID: 11594519
[TBL] [Abstract][Full Text] [Related]
5. [Hodgkin's and Reed-Sternberg cells in the peripheral blood of a patient with advanced stage Hodgkin's disease].
Milosević R; Colović M; Cemerikić-Martinović V; Colović N; Bogunović M
Srp Arh Celok Lek; 2003; 131(9-10):400-2. PubMed ID: 15058220
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous CD30 (Ki-1)-positive anaplastic large cell lymphoma preceded by Hodgkin's disease.
Terao H; Kiryu H; Ohshima K; Kikuchi M; Furue M
J Dermatol; 2000 Mar; 27(3):170-3. PubMed ID: 10774143
[TBL] [Abstract][Full Text] [Related]
7. Hodgkin's disease following non-Hodgkin's lymphoma. A clinicopathologic and immunophenotypic study of nine cases.
Zarate-Osorno A; Medeiros LJ; Kingma DW; Longo DL; Jaffe ES
Am J Surg Pathol; 1993 Feb; 17(2):123-32. PubMed ID: 8422110
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow involvement in T-cell-rich B-cell lymphoma.
Skinnider BF; Connors JM; Gascoyne RD
Am J Clin Pathol; 1997 Nov; 108(5):570-8. PubMed ID: 9353097
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma.
Dann EJ; Daugherty CK; Larson RA
Bone Marrow Transplant; 1997 Sep; 20(5):369-74. PubMed ID: 9339751
[TBL] [Abstract][Full Text] [Related]
10. Extranodal lymphocyte predominance Hodgkin's disease. Clinical and pathologic features.
Siebert JD; Stuckey JH; Kurtin PJ; Banks PM
Am J Clin Pathol; 1995 Apr; 103(4):485-91. PubMed ID: 7726148
[TBL] [Abstract][Full Text] [Related]
11. Expression of p53, MDM2, p21waf1, bcl-2, and retinoblastoma gene proteins in myelodysplastic syndrome after autologous bone marrow transplantation for lymphoma.
Brynes RK; Wilson CS; Kim AB; McCourty A
Mod Pathol; 1997 Nov; 10(11):1120-7. PubMed ID: 9388063
[TBL] [Abstract][Full Text] [Related]
12. Hodgkin's disease in association with human immunodeficiency virus infection. Pathologic and immunologic features.
Pelstring RJ; Zellmer RB; Sulak LE; Banks PM; Clare N
Cancer; 1991 Apr; 67(7):1865-73. PubMed ID: 2004300
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic bone marrow transplantation for Hodgkin's and non-Hodgkin's lymphoma.
Mendoza E; Territo M; Schiller G; Lill M; Kunkel L; Wolin M
Bone Marrow Transplant; 1995 Feb; 15(2):299-303. PubMed ID: 7773222
[TBL] [Abstract][Full Text] [Related]
14. The development of non-Hodgkin's lymphoma following therapy for Hodgkin's disease.
Kim HD; Bedetti CD; Boggs DR
Cancer; 1980 Dec; 46(12):2596-602. PubMed ID: 7448698
[TBL] [Abstract][Full Text] [Related]
15. CD30 (Ki-1)-positive malignant lymphomas: clinical, immunophenotypic, histologic, and genetic characteristics and differences with Hodgkin's disease.
Filippa DA; Ladanyi M; Wollner N; Straus DJ; O'Brien JP; Portlock C; Gangi M; Sun M
Blood; 1996 Apr; 87(7):2905-17. PubMed ID: 8639911
[TBL] [Abstract][Full Text] [Related]
16. Expression of T-cell antigens on Reed-Sternberg cells in a subset of patients with nodular sclerosing and mixed cellularity Hodgkin's disease.
Kadin ME; Muramoto L; Said J
Am J Pathol; 1988 Feb; 130(2):345-53. PubMed ID: 2963547
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow manifestations of Hodgkin's disease.
O'Carroll DI; McKenna RW; Brunning RD
Cancer; 1976 Oct; 38(4):1717-28. PubMed ID: 991090
[TBL] [Abstract][Full Text] [Related]
18. Practice guidelines for the management of extranodal non-Hodgkin's lymphomas of adult non-immunodeficient patients. Part I: primary lung and mediastinal lymphomas. A project of the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.
Zinzani PL; Martelli M; Poletti V; Vitolo U; Gobbi PG; Chisesi T; Barosi G; Ferreri AJ; Marchetti M; Pimpinelli N; Tura S; ; ;
Haematologica; 2008 Sep; 93(9):1364-71. PubMed ID: 18603558
[TBL] [Abstract][Full Text] [Related]
19. Fatal eosinophilic disease following autologous bone marrow transplantation.
Gross TG; Hoge FJ; Jackson JD; Sammut PH; Warkentin PI
Bone Marrow Transplant; 1994 Aug; 14(2):333-7. PubMed ID: 7994253
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of Hodgkin's disease in Kampala, Uganda.
Tumwine LK
East Afr Med J; 2004 Aug; 81(8):384-7. PubMed ID: 15622930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
